MiMedx Group (MDXG) Reports Q4 EPS of 5c

MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.05, $0.03 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69.9 million versus the consensus estimate of $71.13 million.

GUIDANCE:

MiMedx Group sees FY2017 EPS of $0.31-$0.33, versus the consensus of $0.32. MiMedx Group sees FY2017 revenue of $302-307 million, versus the consensus of $304.8 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ennis (EBF) Reports In-Line Q1 EPS
• Jefferies Reinstates Talen Energy (TLN) at Hold